Candel Therapeutics, Inc. - CADL
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 17
Latest filed: May 15, 2026
| Form | Count |
|---|---|
| 4 | 9 |
| 8-K | 5 |
| SCHEDULE 13G | 2 |
| SCHEDULE 13D/A | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| May 15, 2026 | 8-K | May 15, 2026 | 0001193125-26-226751 | View |
| May 15, 2026 | SCHEDULE 13G | — | 0001493215-26-000094 | View |
| May 14, 2026 | 8-K | May 14, 2026 | 0001193125-26-222892 | View |
| Apr 02, 2026 | 4 | Mar 31, 2026 | 0001979825-26-000002 | View |
| Apr 02, 2026 | 4 | Mar 31, 2026 | 0001242215-26-000010 | View |
| Apr 02, 2026 | 4 | Mar 31, 2026 | 0001494695-26-000007 | View |
| Mar 18, 2026 | SCHEDULE 13D/A | — | 0001494695-26-000005 | View |
| Mar 12, 2026 | 8-K | Mar 12, 2026 | 0001193125-26-103126 | View |
| Feb 26, 2026 | 4 | Feb 23, 2026 | 0001193125-26-078246 | View |
| Feb 23, 2026 | 8-K | Feb 19, 2026 | 0001193125-26-062490 | View |
| Feb 19, 2026 | 8-K | Feb 19, 2026 | 0001193125-26-059334 | View |
| Jan 28, 2026 | 4 | Jan 26, 2026 | 0001193125-26-027392 | View |
| Jan 28, 2026 | 4 | Jan 26, 2026 | 0001193125-26-027396 | View |
| Jan 28, 2026 | 4 | Jan 26, 2026 | 0001193125-26-027406 | View |
| Jan 28, 2026 | 4 | Jan 26, 2026 | 0001193125-26-027409 | View |
| Jan 28, 2026 | 4 | Jan 26, 2026 | 0001193125-26-027412 | View |
| Jan 21, 2026 | SCHEDULE 13G | — | 0002012383-26-000746 | View |